Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker SLN
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | SLN Silence Therapeutics Plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 19, 2026 | SLN Silence Therapeutics Plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 19, 2026 | SLN Silence Therapeutics Plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 12, 2026 | SLN Silence Therapeutics Plc | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 12, 2026 | SLN Silence Therapeutics Plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 10, 2026 | SLN Silence Therapeutics Plc | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 10, 2026 | SLN Silence Therapeutics Plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 10, 2026 | SLN Silence Therapeutics Plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 16, 2026 | SLN Silence Therapeutics Plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Jun 23, 2026 | SLN Silence Therapeutics Plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 16, 2026 | SLN Silence Therapeutics Plc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 11, 2026 | SLN Silence Therapeutics Plc | 8.01 Other Events | 8-K | 8-K ↗ |
| May 18, 2026 | SLN Silence Therapeutics Plc | 8.01 Other Events | 8-K | 8-K ↗ |
| May 18, 2026 | SLN Silence Therapeutics Plc | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 18, 2026 | SLN Silence Therapeutics Plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 7, 2026 | SLN Silence Therapeutics Plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 5, 2026 | SLN Silence Therapeutics Plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 5, 2026 | SLN Silence Therapeutics Plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 22, 2025 | SLN Silence Therapeutics Plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Dec 22, 2025 | SLN Silence Therapeutics Plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 15, 2025 | SLN Silence Therapeutics Plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 15, 2025 | SLN Silence Therapeutics Plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 6, 2025 | SLN Silence Therapeutics Plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 23, 2025 | SLN Silence Therapeutics Plc | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 14, 2025 | SLN Silence Therapeutics Plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 7, 2025 | SLN Silence Therapeutics Plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 27, 2025 | SLN Silence Therapeutics Plc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 8, 2025 | SLN Silence Therapeutics Plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 6, 2025 | SLN Silence Therapeutics Plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 6, 2025 | SLN Silence Therapeutics Plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 27, 2025 | SLN Silence Therapeutics Plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 27, 2025 | SLN Silence Therapeutics Plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 2, 2025 | SLN Silence Therapeutics Plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:35 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances